https://www.selleckchem.com/products/cx-5461.html
Very few antibiotics are in clinical development. The arrival of these new antibiotics was welcomed with great enthusiasm, particularly when they met previously unmet medical needs. Unfortunately, the majority of them represent modifications to existing chemical structures rather than new drug classes. Despite the availability of these antibiotics, managing patients with deep-seated infections and those with extensively resistant gram-negative organisms remains challenging. The number of new antibiotics and their indications are not kee
Like
Comment
Share
